Showing 931-940 of 23043 results for "".
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
https://reachmd.com/programs/cme/the-underestimated-consequences-of-uncontrolled-gout-renal-and-cardiovascular-implications/15702/Our experts offer tips to rapidly and sustainably lower serum uric acid levels to <6 mg/dL in your patients with CKD & uncontrolled refractory gout.Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
https://reachmd.com/programs/project-oncology/dato-dxd-nsclc-tropion-lung01-data/36610/As brain metastases continue to complicate treatment decisions in advanced non-small cell lung cancer (NSCLC), recent evidence is shifting the therapeutic landscape. Data from a post-hoc analysis of TROPION-Lung01—presented at the 2025 World Conference on Lung Cancer—demonstrate meaningful intracraThe State of Veterans Affairs with Dr. David Shulkin, VA Under Secretary of Health
https://reachmd.com/programs/your-career-in-healthcare/state-veterans-affairs-dr-david-shulkin-va-under-secretary-health/8012/The Veterans Health Administration operates one of the largest healthcare systems in the world, and provides training for a majority of American clinicians across all levels of practice. Joining host Tim Rush to discuss the state of the VA is Dr. David Shulkin, Under Secretary of Health for the UnitThe Importance of Early Intervention for Psoriatic Arthritis
https://reachmd.com/programs/practical-dermatology-focus-psoriasis/importance-early-intervention-psoriatic-arthritis/29076/Psoriatic arthritis continues to be one of the most common and chronic manifestations of psoriatic disease. Practical Dermatology® spoke with G. Michael Lewitt, who sits on the Medical Board of the National Psoriasis Foundation, to discuss diagnosis and treatment strategies for psoriatic arthritis.From Pixels to Practice: Advancing HCM Care With Multimodality Imaging
https://reachmd.com/programs/cme/from-pixels-to-practice-advancing-hcm-care-with-multimodality-imaging/39877/Explore how multimodality imaging advances diagnosis, treatment selection, and monitoring in hypertrophic cardiomyopathy care.Missing the Window in Ambulatory Patients With HFrEF on GDMT: Strategies for CV Risk Reduction
https://reachmd.com/programs/cme/missing-the-window-in-ambulatory-patients-with-hfref-on-gdmt-strategies-for-cv-risk-reduction/48813/What is the optimal timing for adding evidence-based therapies beyond GDMT in patients with HFrEF? Explore this topic with Drs. Greene and Savarese.GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
https://reachmd.com/programs/cme/gdmt-is-working-fine-so-why-add-more-therapies-for-patients-with-hfref/48811/Which patients with HFrEF may benefit from additional evidence-based therapies beyond GDMT? Join Drs. Lam and Bauersachs in this case-based discussion.An Overview of Topical Therapies for Managing Pediatric AD
https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/Moisturization is foundational in AD management; no specific formulation has demonstrated superiority, and excessive bathing may worsen disease via increased transepidermal water loss. Topical corticosteroids and calcineurin inhibitors remain first-line due to strong efficacy data, cost-effectiveneWhen Doctors 'Google' Their Patients
https://reachmd.com/programs/primary-care-today/when-doctors-google-their-patients/6895/"Doctors 'Google' their patients. In fact, the vast majority of physicians I know have done so... But it surprises me that more physicians don't pause and think about what it means for the patient-doctor relationship." This an excerpt by physician and author Dr. Haider Warraich from his New York TimDuchenne Muscular Dystrophy: Differentiating Advances in Treatment
https://reachmd.com/programs/cme/duchenne-muscular-dystrophy-differentiating-advances-in-treatment/16654/While glucocorticoids are the current SOC for DMD, long-term exposure comes with debilitating side effects. A safer and more effective option is emerging.